SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-241849
Filing Date
2023-09-26
Accepted
2023-09-26 07:34:28
Documents
15
Period of Report
2023-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d473253d8k.htm   iXBRL 8-K 26118
2 EX-99.1 d473253dex991.htm EX-99.1 27868
6 GRAPHIC g473253g0926084738605.jpg GRAPHIC 2425
7 GRAPHIC g473253g0926084738867.jpg GRAPHIC 12476
  Complete submission text file 0001193125-23-241849.txt   202775

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20230926.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20230926_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20230926_pre.xml EX-101.PRE 10815
9 EXTRACTED XBRL INSTANCE DOCUMENT d473253d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 231277164
SIC: 2834 Pharmaceutical Preparations